Back
Aclaris Therapeutics Vs. Repligen Industry Stock Comparison
Buy
51
ACRS
Aclaris Therapeutics
Last Price:
1.17
Seasonality Move:
-1.7%
Buy
59
RGEN
Repligen
Last Price:
145.96
Seasonality Move:
-3.63%
Buy
51
Aclaris Therapeutics (ACRS)
is a Buy
Is Aclaris Therapeutics a Buy, Sell or Hold?
- The current Aclaris Therapeutics [ACRS] share price is $1.17. The Score for ACRS is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- ACRS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
59
Repligen (RGEN)
is a Buy
Is Repligen a Buy, Sell or Hold?
- The current Repligen [RGEN] share price is $147.15. The Score for RGEN is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- RGEN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ACRS Stock Price Chart
What is Aclaris Therapeutics's stock price today?
-
The Aclaris Therapeutics share price today is $1.17
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACRS is experiencing buying pressure, which is a positive indicator for future bullish movement.
RGEN Stock Price Chart
ACRS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 48.14 | Sell |
| Chaikin Money Flow: | 211603 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.16 - 1.2) | Sell |
| Bollinger Bands (100): | (1.11 - 1.29) | Sell |
RGEN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.47 | Sell |
| Relative Strength Index (14 RSI): | 52.94 | Buy |
| Chaikin Money Flow: | 229723 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (140.83 - 147.73) | Buy |
| Bollinger Bands (100): | (129.58 - 161.14) | Buy |
ACRS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.17 | Buy |
| 20-day SMA: | 1.17 | Sell |
| 50-day SMA: | 1.22 | Sell |
| 200-day SMA: | 1.19 | Sell |
| 8-day EMA: | 1.16 | Buy |
| 20-day EMA: | 1.18 | Sell |
| 50-day EMA: | 1.2 | Sell |
| 200-day EMA: | 2.05 | Sell |
RGEN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 142.16 | Buy |
| 20-day SMA: | 143.7 | Buy |
| 50-day SMA: | 147.91 | Sell |
| 200-day SMA: | 164.35 | Sell |
| 8-day EMA: | 142.92 | Buy |
| 20-day EMA: | 144.02 | Buy |
| 50-day EMA: | 145.55 | Buy |
| 200-day EMA: | 155.82 | Sell |
Aclaris Therapeutics Earnings Growth & ACRS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.48 per share, a decrease next quarter of $0.13 per share, an increase this year of $1.08 per share, and a decrease next year of $0.09 per share.
Repligen Earnings Growth & RGEN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, an increase next quarter of $0.13 per share, a decrease this year of $0.27 per share, and an increase next year of $0.44 per share.
Aclaris Therapeutics Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Repligen Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||